Johnson & Johnson Starts New Late Stage COVID-19 Vaccine Trial

Johnson & Johnson Starts New Late Stage COVID-19 Vaccine Trial

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the testing of an A2 dose regimen for an experimental COVID-19 vaccine, focusing on the potential benefits of a second dose. The study aims to include up to 30,000 participants, while a previous A1 dose trial involved around 60,000 people. Additionally, Pfizer and BioNTech reported that their vaccine showed an efficacy rate of over 90%.

Read more

1 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF